Overview

A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED)

Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
This study will determine the effect of concomitant administration of sitagliptin and metformin on post-meal incretin hormone concentrations in healthy adults.
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Gastric Inhibitory Polypeptide
Hormones
Incretins
Metformin
Sitagliptin Phosphate